Axolabs, a growing company located in Kulmbach (Bavaria, Germany) and Berlin, is a member of the globally active LGC Group. As the world’s leading Custom Research Organization (CRO) in the field of DNA-/RNA-based therapeutics we are committed to the development of innovative drugs. We offer a broad range of services for therapeutic oligonucleotides and mRNAs covering bioinformatics, chemical synthesis of oligonucleotides, oligonucleotide conjugates and formulations, analytics, bioanalytics, in vitro and in vivo testing. Due to 21 years of experience in the field we are well known from big pharma and biotech to academia and venture capital for our profound knowledge, high quality standards and excellent research. The recently founded Axolabs Berlin GmbH is newly established as a contract manufacturer (GMP) for chemical DNA/RNA therapeutics in Berlin. The LGC Group is thus expanding its expertise in the field of nucleic acid-based therapeutics, which are currently already bundled in the companies Axolabs GmbH, Kulmbach, and LGC Biosearch Technologies, Petaluma, USA. Services: bioinformatics, oligonucleotide synthesis, analytics and in vitro / in vivo analysis.